Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity

Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Masters, C. L., Simms, G., Weinman, N. A., Multhaup, G., McDonald, B. L., & Beyreuther, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.12.4245 · Cited by 4,431

Neurodegenerative diseases and oxidative stress

Barnham, K. J., Masters, C. L., & Bush, A. I. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1330 · Cited by 3,683

The neurobiology of zinc in health and disease

Frederickson, C. J., Koh, J., & Bush, A. I. (2005) · Nature reviews. Neuroscience · doi:10.1038/nrn1671 · Cited by 1,841

Treatment with a Copper-Zinc Chelator Markedly and Rapidly Inhibits β-Amyloid Accumulation in Alzheimer's Disease Transgenic Mice

Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447

The metallobiology of Alzheimer's disease

Bush, A. I. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00067-5 · Cited by 1,315

GSK-3α regulates production of Alzheimer's disease amyloid-β peptides

Phiel, C. J., Wilson, C., Lee, V. M. ‐., & Klein, P. S. (2003) · Nature · doi:10.1038/nature01640 · Cited by 1,211

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease: A Pilot Phase 2 Clinical Trial

Ritchie, C. W., Bush, A. I., Mackinnon, A., Macfarlane, S., Mastwyk, M., MacGregor, L., Kiers, L., Cherny, R., Li, Q.-X., Tammer, A., et al. (2003) · Archives of Neurology · doi:10.1001/archneur.60.12.1685 · Cited by 988

Multiple Roles of the PI3K/PKB (Akt) Pathway in Cell Cycle Progression

Liang, J., & Slingerland, J. M. (2003) · Cell Cycle · doi:10.4161/cc.2.4.433 · Cited by 885

Enhanced Proteolysis of β-Amyloid in APP Transgenic Mice Prevents Plaque Formation, Secondary Pathology, and Premature Death

Leissring, M. A., Farris, W., Chang, A. Y., Walsh, D. M., Wu, X., Sun, X., Frosch, M. P., & Selkoe, D. J. (2003) · Neuron · doi:10.1016/s0896-6273(03)00787-6 · Cited by 725

Genetic or Pharmacological Iron Chelation Prevents MPTP-Induced Neurotoxicity In Vivo

Kaur, D., Yantiri, F., Rajagopalan, S., Kumar, J., Mo, J. Q., Boonplueang, R., Viswanath, V., Jacobs, R., Yang, L., Beal, M. F., et al. (2003) · Neuron · doi:10.1016/s0896-6273(03)00126-0 · Cited by 620

Alzheimer’s disease: Clinical trials and drug development

Mangialasche, F., Solomon, A., Winblad, B., Mecocci, P., & Kivipelto, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70119-8 · Cited by 1,217

Targeting Free Radicals in Oxidative Stress-Related Human Diseases

Poprac, P., Jomova, K., Simunkova, M., Kollar, V., Rhodes, C. J., & Valko, M. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.04.005 · Cited by 1,107

Metals, oxidative stress and neurodegenerative disorders

Jomová, K., Vondráková, D., Lawson, M. K., & Valko, M. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0563-x · Cited by 1,074

Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

Rempe, R. G., Hartz, A. M., & Bauer, B. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16655551 · Cited by 721

Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ

Adlard, P. A., Cherny, R. A., Finkelstein, D. I., Gautier, E., Robb, E., Cortes, M., Volitakis, I., Liu, X., Smith, J. P., Perez, K., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.018 · Cited by 672

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 612

Therapeutics for Alzheimer's Disease Based on the Metal Hypothesis

Bush, A. I., & Tanzi, R. E. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.001 · Cited by 582

Amyloid β -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526

Metabolism and functions of copper in brain

Scheiber, I. F., Mercer, J. F. B., & Dringen, R. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.01.002 · Cited by 524

Copper in the brain and Alzheimer’s disease

Hung, Y. H., Bush, A. I., & Cherny, R. A. (2009) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-009-0600-y · Cited by 503

8-Hydroxyquinolines: a review of their metal chelating properties and medicinal applications

Prachayasittikul, V., Prachayasittikul, V., Prachayasittikul, S., & Ruchirawat, S. (2013) · Drug Design Development and Therapy · doi:10.2147/dddt.s49763 · Cited by 461

Metal dyshomeostasis and oxidative stress in Alzheimer’s disease

Greenough, M. A., Camakaris, J., & Bush, A. I. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.08.014 · Cited by 447

The Biochemical, Biological, and Pathological Kaleidoscope of Cell Surface Substrates Processed by Matrix Metalloproteinases

Cauwe, B., den Steen, P. E. V., & Opdenakker, G. (2007) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409230701340019 · Cited by 389

Alzheimer's disease, metal ions and metal homeostatic therapy

Zatta, P., Drago, D., Bolognin, S., & Sensi, S. L. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.002 · Cited by 369

Metallostasis in Alzheimer's disease

Ayton, S., Lei, P., & Bush, A. I. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.10.558 · Cited by 359

Medicinal Inorganic Chemistry Approaches to Passivation and Removal of Aberrant Metal Ions in Disease

Scott, L. E., & Orvig, C. (2009) · Chemical Reviews · doi:10.1021/cr9000176 · Cited by 332

Copper complexes of bis(thiosemicarbazones): from chemotherapeutics to diagnostic and therapeutic radiopharmaceuticals

Paterson, B. M., & Donnelly, P. S. (2011) · Chemical Society Reviews · doi:10.1039/c0cs00215a · Cited by 298

Activation of Wnt signaling by lithium and rosiglitazone reduced spatial memory impairment and neurodegeneration in brains of an APPswe/PSEN1ΔE9 mouse model of Alzheimer's disease

Toledo, E. M., & Inestrosa, N. C. (2009) · Molecular Psychiatry · doi:10.1038/mp.2009.72 · Cited by 292

Copper complexes as therapeutic agents

Duncan, C., & White, A. R. (2011) · Metallomics · doi:10.1039/c2mt00174h · Cited by 297

Copper and Oxidative Stress in the Pathogenesis of Alzheimer’s Disease

Eskici, G., & Axelsen, P. H. (2012) · Biochemistry · doi:10.1021/bi3006169 · Cited by 291

8-Hydroxyquinolines in medicinal chemistry: A structural perspective

Oliveri, V., & Vecchio, G. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.05.007 · Cited by 282

Biological metals and Alzheimer's disease: Implications for therapeutics and diagnostics

Duce, J. A., & Bush, A. I. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.04.003 · Cited by 288

Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation

Crouch, P. J., Hung, L. W., Adlard, P. A., Cortés, M., Lal, V., Filiz, G., Perez, K. A., Nurjono, M., Caragounis, A., Du, T., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809057106 · Cited by 288

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279

Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes

Zuroff, L. R., Daley, D. A., Black, K. L., & Koronyo‐Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 292

Inhibition of γ‐secretase causes increased secretion of amyloid precursor protein C‐terminal fragments in association with exosomes

Sharples, R. A., Vella, L. J., Nisbet, R. M., Naylor, R., Perez, K. A., Barnham, K. J., Masters, C. L., & Hill, A. F. (2008) · The FASEB Journal · doi:10.1096/fj.07-9357com · Cited by 253

Utility of an improved model of amyloid-beta (Aβ1-42) toxicity in Caenorhabditis elegans for drug screening for Alzheimer’s disease

McColl, G., Roberts, B. R., Pukala, T. L., Kenche, V. B., Roberts, C. M., Link, C. D., Ryan, T. M., Masters, C. L., Barnham, K. J., Bush, A. I., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-57 · Cited by 257

The transition metals copper and iron in neurodegenerative diseases

Rivera-Mancía, S., Pérez‐Neri, I., Ríos, C., Tristán-López, L. A., Rivera-Espinosa, L., & Montes, S. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.04.010 · Cited by 247

Interactions of Zn(ii) and Cu(ii) ions with Alzheimer's amyloid-beta peptide. Metal ion binding, contribution to fibrillization and toxicity

Tõugu, V., Tiiman, A., & Palumaa, P. (2011) · Metallomics · doi:10.1039/c0mt00073f · Cited by 224

Melatonin in Alzheimer’s Disease

Li, L., Qiong-xia, H., Yang, S.-S., Chu, J., Wang, J., & Tian, Q. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140714575 · Cited by 229

Friends or foes: matrix metalloproteinases and their multifaceted roles in neurodegenerative diseases

Brkic, M., Balusu, S., Libert, C., & Vandenbroucke, R. E. (2015) · Mediators of Inflammation · doi:10.1155/2015/620581 · Cited by 205

Copper as a key regulator of cell signalling pathways

Grubman, A., & White, A. R. (2014) · Expert Reviews in Molecular Medicine · doi:10.1017/erm.2014.11 · Cited by 199

Selective Intracellular Release of Copper and Zinc Ions from Bis(thiosemicarbazonato) Complexes Reduces Levels of Alzheimer Disease Amyloid-β Peptide

Donnelly, P. S., Caragounis, A., Du, T., Laughton, K. M., Volitakis, I., Cherny, R. A., Sharples, R. A., Hill, A. F., Li, Q., Masters, C. L., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m705957200 · Cited by 196

Role of ABCG1 and ABCA1 in Regulation of Neuronal Cholesterol Efflux to Apolipoprotein E Discs and Suppression of Amyloid-β Peptide Generation

Kim, W. S., Rahmanto, A. S., Kamili, A., Rye, K.-A., Guillemin, G. J., Gelissen, I. C., Jessup, W., Hill, A. F., & Garner, B. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607831200 · Cited by 191

Ceria/POMs hybrid nanoparticles as a mimicking metallopeptidase for treatment of neurotoxicity of amyloid-β peptide

Guan, Y., Li, M. C., Dong, K., Gao, N., Ren, J., Zheng, Y.-C., & Qu, X. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.05.005 · Cited by 190

Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives

Behl, T., Kaur, G., Sehgal, A., Bhardwaj, S., Singh, S., Buhaș, C. L., Pusta, C. T. J., Uivaroșan, D., Munteanu, M. A., & BUNGAU, S. G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031413 · Cited by 198

Are amyloid-degrading enzymes viable therapeutic targets in Alzheimer’s disease?

Nalivaeva, N. N., Beckett, C., Belyaev, N. D., & Turner, A. J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07510.x · Cited by 169

Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction

Corona, C., Masciopinto, F., Silvestri, E., Viscovo, A. D., Lattanzio, R., Sorda, R. L., Ciavardelli, D., Goglia, F., Piantelli, M., Canzoniero, L. M. T., et al. (2010) · Cell Death and Disease · doi:10.1038/cddis.2010.73 · Cited by 189

Insights into Zn2+ homeostasis in neurons from experimental and modeling studies

Colvin, R. A., Bush, A. I., Volitakis, I., Fontaine, C. P., Thomas, D. G., Kikuchi, K., & Holmes, W. R. (2008) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00541.2007 · Cited by 190

Copper and Alzheimer's disease

Donnelly, P. S., Xiao, Z., & Wedd, A. G. (2007) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2007.01.678 · Cited by 188

The Alzheimer’s therapeutic PBT2 promotes amyloid‐β degradation and GSK3 phosphorylation via a metal chaperone activity

Crouch, P. J., Savva, M. S., Hung, L. W., Donnelly, P. S., Mot, A. I., Parker, S. J., Greenough, M. A., Volitakis, I., Adlard, P. A., Cherny, R. A., et al. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07402.x · Cited by 183

Zn(II)‐ and Cu(II)‐induced non‐fibrillar aggregates of amyloid‐β (1–42) peptide are transformed to amyloid fibrils, both spontaneously and under the influence of metal chelators

Tõugu, V., Karafin, A., Zovo, K., Chung, R. S., Howells, C., West, A. K., & Palumaa, P. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06269.x · Cited by 181

Biomedical applications of copper ionophores

Oliveri, V. (2020) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2020.213474 · Cited by 175

Neprilysin and Aβ Clearance: Impact of the APP Intracellular Domain in NEP Regulation and Implications in Alzheimer’s Disease

Grimm, M. O. W., Mett, J., Stahlmann, C. P., Haupenthal, V. J., Zimmer, V. C., & Hartmann, T. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00098 · Cited by 170

Metal Ion Physiopathology in Neurodegenerative Disorders

Bolognin, S., Luigi Messori, A., & Zatta, P. F. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8102-1 · Cited by 159

Copper deficiency and neurological disorders in man and animals

Zatta, P. F., & Frank, A. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2006.10.001 · Cited by 159

Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid

Altschul, D., Launer, L. J., Adlard, P. A., Cherny, R. A., Tsatsanis, A., Volitakis, I., Blennow, K., Petrovitch, H., White, L. R., & Bush, A. I. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.10.012 · Cited by 154

Alzheimer’s disease: How metal ions define β-amyloid function

Kepp, K. P. (2017) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2017.05.007 · Cited by 154

Metalloproteinase-9 deficiency protects against hepatic ischemia/reperfusion injury

Hamada, T., Fondevila, C., Busuttil, R. W., & Coito, A. J. (2007) · Hepatology · doi:10.1002/hep.21922 · Cited by 148

Copper Toxicity Links to Pathogenesis of Alzheimer’s Disease and Therapeutics Approaches

Ijaz, H. W., Wang, W., & Lang, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207660 · Cited by 146

Alzheimer's disease & metals: therapeutic opportunities

Kenche, V. B., & Barnham, K. J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01221.x · Cited by 147

Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model

Zhao, L., Wang, J., Wang, Y.-R., & Fa, X.-Z. (2012) · Brain Research · doi:10.1016/j.brainres.2012.11.019 · Cited by 140

Metal ionophores – An emerging class of anticancer drugs

Ding, W., & Lind, S. E. (2009) · IUBMB Life · doi:10.1002/iub.253 · Cited by 143

Strategies for the Inhibition of Protein Aggregation in Human Diseases

Bartolini, M., & Andrisano, V. (2010) · ChemBioChem · doi:10.1002/cbic.200900666 · Cited by 140

Copper dyshomoeostasis in Parkinson's disease: implications for pathogenesis and indications for novel therapeutics

Davies, K. M., Mercer, J. F. B., Chen, N., & Double, K. L. (2016) · Clinical Science · doi:10.1042/cs20150153 · Cited by 139

ATP‐binding cassette transporter A7 regulates processing of amyloid precursor protein in vitro

Chan, S. L., Kim, W. S., Kwok, J. B., Hill, A. F., Cappai, R., Rye, K., & Garner, B. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05433.x · Cited by 135

The role of copper ions in pathophysiology and fluorescent sensors for the detection thereof

Verwilst, P., Sunwoo, K., & Kim, J. S. (2015) · Chemical Communications · doi:10.1039/c4cc10366a · Cited by 133

Clioquinol Decreases Amyloid-β Burden and Reduces Working Memory Impairment in a Transgenic Mouse Model of Alzheimer's Disease

Grossi, C., Francese, S., Casini, A., Rosi, M. C., Luccarini, I., Fiorentini, A., Gabbiani, C., Luigi Messori, A., Moneti, G., & Casamenti, F. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1063 · Cited by 131

Genome-wide association study of CSF levels of 59 Alzheimer's disease candidate proteins: significant associations with proteins involved in amyloid processing and inflammation

Kauwe, J. S. K., Bailey, M. H., Ridge, P. G., Perry, R., Wadsworth, M. E., Hoyt, K. L., Staley, L. A., Karch, C. M., Harari, O., Cruchaga, C., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004758 · Cited by 125

Methionine-35 of A β (1–42): Importance for Oxidative Stress in Alzheimer Disease

Butterfield, D. A., & Sultana, R. (2011) · Journal of Amino Acids · doi:10.4061/2011/198430 · Cited by 124

Therapeutic Redistribution of Metal Ions To Treat Alzheimer’s Disease

Crouch, P. J., & Barnham, K. J. (2012) · Accounts of Chemical Research · doi:10.1021/ar300074t · Cited by 125

Zinc induces protein phosphatase 2A inactivation and tau hyperphosphorylation through Src dependent PP2A (tyrosine 307) phosphorylation

Xiong, Y., Jing, X.-P., Zhou, X.-W., Wang, X.-L., Yang, Y., Sun, X.-Y., Qiu, M., Cao, F.-Y., Lu, Y.-M., Liu, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.003 · Cited by 122

The High Mobility Group A1 (HMGA1) Transcriptome in Cancer and Development

Sumter, T. F., Xian, L., Huso, T. H., Koo, M., Chang, Y.-T., Almasri, T. N., Chia, L., Inglis, C., Reid, D., & Resar, L. M. S. (2016) · Current Molecular Medicine · doi:10.2174/1566524016666160316152147 · Cited by 122

Role of matrix metalloproteinase-3 in neurodegeneration

Kim, E., & Hwang, O. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07082.x · Cited by 114

Pathophysiological Mechanisms Explaining the Association Between Low Skeletal Muscle Mass and Cognitive Function

Oudbier, S. J., Goh, J., Looijaard, S. M. L. M., Reijnierse, E. M., Meskers, C. G. M., & Maier, A. B. (2022) · The Journals of Gerontology Series A · doi:10.1093/gerona/glac121 · Cited by 125

Amyloid plaques arise from zinc-enriched cortical layers in APP/PS1 transgenic mice and are paradoxically enlarged with dietary zinc deficiency

Stoltenberg, M., Bush, A. I., Bach, G., Smidt, K., Larsen, A., Rungby, J., Lund, S. A., Doering, P., & Danscher, G. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.025 · Cited by 114

Metalloproteinases and their tissue inhibitors in Alzheimer’s disease and other neurodegenerative disorders.

Rivera, S., García-González, L., Khrestchatisky, M., & Baranger, K. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03178-2 · Cited by 111

Matrix metalloproteinases in peripheral blood and cerebrospinal fluid in patients with Alzheimer's disease

Horstmann, S., Budig, L., Gardner, H., Koziol, J. A., Deuschle, M., Schilling, C., & Wagner, S. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000827 · Cited by 111

Copper and Alzheimer’s Disease

Mathys, Z. K., & White, A. R. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-60189-2_10 · Cited by 115

Delineating the Mechanism of Alzheimer’s Disease Aβ Peptide Neurotoxicity

Cappai, R., & Barnham, K. J. (2008) · Neurochemical Research · doi:10.1007/s11064-007-9469-8 · Cited by 108

Pharmacological activity of metal binding agents that alter copper bioavailability

Helsel, M. E., & Franz, K. J. (2015) · Dalton Transactions · doi:10.1039/c5dt00634a · Cited by 113

Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease

Davies, D. A., Adlimoghaddam, A., & Albensi, B. C. (2021) · Cells · doi:10.3390/cells10081884 · Cited by 112

Small molecule inhibitors of Aβ‐aggregation and neurotoxicity

Hawkes, C. A., Ng, V., & McLaurin, J. (2009) · Drug Development Research · doi:10.1002/ddr.20290 · Cited by 105

Site-Activated Chelators Targeting Acetylcholinesterase and Monoamine Oxidase for Alzheimer’s Therapy

Zheng, H., Youdim, M. B. H., & Fridkin, M. (2010) · ACS Chemical Biology · doi:10.1021/cb900264w · Cited by 99

Intraneuronal Aβ accumulation induces hippocampal neuron hyperexcitability through A-type K+ current inhibition mediated by activation of caspases and GSK-3

Scala, F., Fusco, S., Ripoli, C., Piacentini, R., Puma, D. D. L., Spinelli, M., Laezza, F., Grassi, C., & D’Ascenzo, M. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.034 · Cited by 98

Matrix Metalloproteinases as New Targets in Alzheimer’s Disease: Opportunities and Challenges

Zipfel, P., Rochais, C., Baranger, K., Rivera, S., & Dallemagne, P. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00352 · Cited by 94

The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease

Drew, S. C. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00317 · Cited by 93

Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer’s disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery

Vilella, A., Belletti, D., Sauer, A. K., Hagmeyer, S., Sarowar, T., Masoni, M., Stasiak, N., Mulvihill, J. J., Ruozi, B., Forni, F., et al. (2017) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2017.12.006 · Cited by 92

8-Hydroxyquinoline Schiff-base compounds as antioxidants and modulators of copper-mediated Aβ peptide aggregation

Gomes, L. M., Vieira, R. P., Jones, M. R., Wang, M. C. P., Dyrager, C., de Souza-Fagundes, E. M., Silva, J. G. D., Storr, T., & Beraldo, H. D. O. (2014) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2014.04.011 · Cited by 94

Iron and Copper Intracellular Chelation as an Anticancer Drug Strategy

Gaur, K., Vázquez-Salgado, A. M., Duran-Camacho, G., Dominguez-Martinez, I., Benjamín-Rivera, J. A., Fernández-Vega, L., Carmona‐Sarabia, L., García, A. C., Pérez-Deliz, F., Román, J. A. M., et al. (2018) · Inorganics · doi:10.3390/inorganics6040126 · Cited by 94

Zinc and Central Nervous System Disorders

Wang, B., Fang, T., & Chen, H. (2023) · Nutrients · doi:10.3390/nu15092140 · Cited by 93

Autophagy: A cell repair mechanism that retards ageing and age-associated diseases and can be intensified pharmacologically

Bergamini, E. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.001 · Cited by 90

The missing link in the amyloid cascade of Alzheimer’s disease – Metal ions

Tiiman, A., Palumaa, P., & Tõugu, V. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.01.023 · Cited by 92

Restored degradation of the Alzheimer’s amyloid‐β peptide by targeting amyloid formation

Crouch, P. J., Tew, D. J., Du, T., Nguyen, D., Caragounis, A., Filiz, G., Blake, R. E., Trounce, I. A., Soon, C. P. W., Laughton, K. M., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.05870.x · Cited by 88

Emerging Alternative Proteinases in APP Metabolism and Alzheimer’s Disease Pathogenesis: A Focus on MT1-MMP and MT5-MMP

García-González, L., Pilat, D., Baranger, K., & Rivera, S. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00244 · Cited by 88

Intracellular copper deficiency increases amyloid-β secretion by diverse mechanisms

Cater, M. A., McInnes, K. T., Li, Q., Volitakis, I., Fontaine, S. L., Mercer, J. F. B., & Bush, A. I. (2008) · Biochemical Journal · doi:10.1042/bj20080103 · Cited by 87

ECM in brain aging and dementia

Morawski, M., Filippov, M., Tzinia, A., Tsilibary, E., & Vargova, L. (2014) · Progress in Brain Research · doi:10.1016/b978-0-444-63486-3.00010-4 · Cited by 84

The AβCs of Aβ-cleaving Proteases*

Leissring, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.r800022200 · Cited by 78

Bis (thiosemicarbazonato) Cu-64 Complexes for Positron Emission Tomography Imaging of Alzheimer's Disease

Fodero‐Tavoletti, M. T., Villemagne, V. L., Paterson, B. M., White, A. R., Li, Q., Camakaris, J., O'Keefe, G. J., Cappai, R., Barnham, K. J., & Donnelly, P. S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1359 · Cited by 83

Novel molecular targets of the neuroprotective/neurorescue multimodal iron chelating drug M30 in the mouse brain

Kupershmidt, L., Weinreb, O., Amit, T., Mandel, S. A., Bar‐Am, O., & Youdim, M. B. H. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.03.040 · Cited by 80

Stoichiometry and conditional stability constants of Cu(II) or Zn(II) clioquinol complexes; implications for Alzheimer's and Huntington's disease therapy

Ferrada, E., Arancibia, V., Bárbara Loeb, L., Norambuena, E., Olea‐Azar, C., & Huidobro-Toro, J. P. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.02.004 · Cited by 81

Neuroprotective Multifunctional Iron Chelators: From Redox-Sensitive Process to Novel Therapeutic Opportunities

Weinreb, O., Amit, T., Mandel, S. A., Kupershmidt, L., & Youdim, M. B. H. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2929 · Cited by 80

Metals in alzheimer's disease: a systemic perspective

Squitti, R. (2011) · Frontiers in bioscience · doi:10.2741/3938 · Cited by 80

PBT2 Reduces Toxicity in a C. elegans Model of polyQ Aggregation and Extends Lifespan, Reduces Striatal Atrophy and Improves Motor Performance in the R6/2 Mouse Model of Huntington's Disease

Cherny, R. A., Ayton, S., Finkelstein, D. I., Bush, A. I., McColl, G., & Massa, S. M. (2012) · Journal of Huntington s Disease · doi:10.3233/jhd-120029 · Cited by 78

Modeling late-onset Alzheimer’s disease neuropathology via direct neuronal reprogramming

Sun, Z., Kwon, J.-S., Ren, Y., Chen, S., Walker, C. K., Lu, X., Cates, K., Karahan, H., Sviben, S., Fitzpatrick, J. A. J., et al. (2024) · Science · doi:10.1126/science.adl2992 · Cited by 77

The modulation of metal bio‐availability as a therapeutic strategy for the treatment of Alzheimer's disease

Crouch, P. J., White, A. R., & Bush, A. I. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05918.x · Cited by 78

Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy

Love, S. (2009) · Frontiers in bioscience · doi:10.2741/3567 · Cited by 78

Aspects of β-Amyloid as a Biomarker for Alzheimer's Disease

Andréasson, U., Portelius, E., Andersson, M. E., Blennow, K., & Zetterberg, H. (2007) · Biomarkers in Medicine · doi:10.2217/17520363.1.1.59 · Cited by 74

The role of GSK3 in Alzheimer disease

Hernández, F., de Barreda, E. G., Fuster-Matanzo, A., Goñi‐Oliver, P., Lucas, J. J., & Ávila, J. (2009) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2009.05.017 · Cited by 73

Stabilization of Nontoxic Aβ-Oligomers: Insights into the Mechanism of Action of Hydroxyquinolines in Alzheimer's Disease

Ryan, T. M., Roberts, B. R., McColl, G., Hare, D. J., Doble, P., Li, Q., Lind, M., Roberts, A. M., Mertens, H. D. T., Kirby, N. M., et al. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2912-14.2015 · Cited by 74

Differential modulation of Alzheimer's disease amyloid β-peptide accumulation by diverse classes of metal ligands

Caragounis, A., Du, T., Filiz, G., Laughton, K. M., Volitakis, I., Sharples, R. A., Cherny, R. A., Masters, C. L., Drew, S. C., Hill, A. F., et al. (2007) · Biochemical Journal · doi:10.1042/bj20070579 · Cited by 63

Clioquinol induces metal-dependent degradation of the Alzheimer's disease amyloid beta peptide by up-regulation of matrix metalloproteases

White, A., Du, T., Laughton, K., Volitakis, I., Sharples, R., Hoke, D., Holsinger, R. M. D., Evin, G. M., Cherny, R., Hill, A. F., et al. (2006) · Journal of Neurochemistry

MMP-7 cleaves amyloid β fragment peptides and copper ion inhibits the degradation

Taniguchi, M., Matsuura, K., Nakamura, R., Kojima, A., Konishi, M., & Akizawa, T. (2017) · BioMetals · doi:10.1007/s10534-017-0048-4 · Cited by 21

The role of metals in modulating metalloprotease activity in the AD brain

Filiz, G., Price, K. A., Caragounis, A., Du, T., Crouch, P. J., & White, A. R. (2008) · European Biophysics Journal · doi:10.1007/s00249-007-0244-1 · Cited by 40

Therapeutic Treatment of Alzheimer's Disease Using Metal Complexing Agents

Price, K. A., Crouch, P. J., & White, A. R. (2010) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/978160805159511001010106